Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation

Immunity

Volumn 4, Issue 6, 1996, Pages 593-602

  Wu, Jun ^c   Motto, David G ^c   Koretzky, Gary A ^b   Weiss, Arthur ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR;

ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; T LYMPHOCYTE ACTIVATION;

EID: 0001584956     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80485-9     Document Type: Article

References (45)

1. Adams, J.M., Houston, H., Allen, J., Lints, T., and Harvey, R. (1992). The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization. Oncogene 7, 611-618.
2. Boguski, M., and McCormick, F. (1993). Proteins regulating Ras and its relatives. Nature 366, 643-654.
3. Boguski, M.S., Bairoch, A., Attwood, T.K., and Michaels, G.S. (1992). Proto-vav and gene expression [letter; comment]. Nature 358, 113.
4. Buday, L., Egan, S.E., Viciana, P.R., Cantrell, D.A., and Downward, J. (1994). A complex of Grb2 adaptor protein, Sos exchange factor, and a 36-kDa membrane-bound tyrosine phosphoprotein is implicated in ras activation in T cells. J. Biol. Chem. 269, 9019-9023.
5. Bustelo, X.R., and Barbacid, M. (1992). Tyrosine phosphorylation of the vav proto-oncogene product in activated B cells. Science 256, 1196-1199.
6. Bustelo, X.R., Ledbetter, J.A., and Barbacid, M. (1992). Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates. Nature 356, 68-71.
7. Bustelo, X.R., Suen, K., Leftheris, K., Meyers, C.A., and Barbacid, M. (1994). Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor. Oncogene 9, 2405-2413.
8. Bustelo, X.R., Suen, K., Michael, W.M., Dreyfuss, G., and Barbacid, M. (1995). Association of the vav proto-oncogene product with poly(rC)-specific RNA-binding proteins. Mol. Cell. Biol. 15, 1324-1332.
9. Chan, A.C., Irving, B.A., Fraser, J.D., and Weiss, A. (1991). The ζ-chain is associated with a tyrosine kinase and upon T cell antigen receptor stimulation associates with ZAP-70, a 70 kilodalton tyrosine phosphoprotein. Proc. Natl. Acad. Sci. USA 88, 9166-9170.
10. Chan, A.C., Iwashima, M., Turck, C.W., and Weiss, A. (1992). ZAP-70: a 70kDa protein tyrosine kinase that associates with the TCR ζ chain. Cell 71, 649-662.
11. Chan, A.C., van Oers, N.S.C., Tran, A., Turka, L., Law, C.-L., Ryan, J.C., Clark, E.A., and Weiss, A. (1994). Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in T cell antigen receptor signaling. J. Immunol. 152, 4758-4766.
12. Clipstone, N.A., and Crabtree, G.R. (1992). Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357, 695-697.
13. Coppola, J., Bryant, S., Koda, T., Conway, D., and Barbacid, M. (1991). Mechanism of activation of the vav proto-oncogene. Cell Growth Diff. 2, 95-105.
14. Evens, G.A., Howard, O.M., Erwin, R., and Farrar, W.L. (1993). Interleukin-2 induces tyrosine phosphorylation of the vav proto-oncogene product in human T cells: lack of requirement for the tyrosine kinase lck. Biochem. J. 294, 339-342.
15. + thymocytes. Nature 374, 474-477.
16. Galland, F., Katzav, S., and Birnbaum, D. (1992). The products of the mcf-2 and vav proto-oncogenes and of the yeast gene cdc-24 share sequence similarities. Oncogene 7, 585-587.
17. Gouy, H., Debre, P., and Bismuth, G. (1995). The proto-oncogene Vav product is constitutively tyrosine-phosphorylated in normal human immature T cells. Eur. J. Immunol. 25, 3030-3034.
18. Gulbins, E., Coggeshall, K.M., Baier, G., Katzav, S., Burn, P., and Altman, A. (1993). Tyrosine kinase-stimulated guanine nucleotide exchange activity of vav in T cell activation. Science 260, 822-825.
19. Gupta, S., Weiss, A., Kumar, G., Wang, S., and Nel, A. (1994). The T-cell antigen receptor utilizes LCK, RAF-1 and MEK-1 for activating MAP kinase: evidence for the existence of a second PKC-dependent pathway in an LCK-negative Jurkat cell mutant. J. Biol. Chem. 269, 17349-17357.
20. Holsinger, L.J., Spencer, D.M., Austin, D.J., Schreiber, S.L., and Crabtree, G.R. (1995). Signal transduction in T lymphocytes using a conditional allele of Sos. Proc. Natl. Acad. Sci. USA 92, 9810-9814.
21. Hobert, O., Jallal, B., Schlessinger, J., and Ullrich, A. (1994). Novel signaling pathway suggested by SH3 domain-mediated p95vav/heterogeneous ribonucleoprotein K interaction. J. Biol. Chem. 269, 20225-20228.
22. Huby, R.D.J., Carille, G., and Ley, S.C. (1995). Interactions between the protein-tyrosine kinase ZAP-70, the proto-oncoprotein Vav, and tubulin in Jurkat T cells. J. Biol. Chem. 270, 30241-30244.
23. Iwashima, M., Irving, B.A., van Oers, N.S.C., Chan, A.C., and Weiss, A. (1994). Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science 263, 1136-1139.
24. Jackman, J.K., Motto, D.G., Sun, Q., Tanemoto, M., Turck, C.W., Peltz, G.A., Koretzky, G.A., and Findell, P.R. (1995). Molecular cloning of SLP-76, a 76-kDa tyrosine phosphoprotein associated with Grb2 in T cells. J. Biol. Chem. 270, 7029-7032.
25. Katzav, S., Martin-Zanca, D., and Barbacid, M. (1989). vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J. 8, 2283-2290.
26. Katzav, S., Cleveland, J.L., Heslop, H.E., and Pulido, D. (1991). Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential. Mol. Cell. Biol. 11, 1912-1920.
27. Katzav, S., Sutherland, M., Packham, G., Yi, T., and Weiss, A. (1994). The protein tyrosine kinase ZAP-70 can associate with the SH2 domain of proto-vav. J. Biol. Chem. 269, 32579-32585.
28. Khosravi-Far, R., Chrzanowska-Wodnicka, M., Solski, P.A., Eva, A., Burridge, K., and Der, C.J. (1994). Dbl and Vav mediate transformation via mitogen-activated protein kinase pathways that are distinct from those activated by oncogenic Ras. Mol. Cell. Biol. 14, 6848-6857.
29. Koch, C.A., Anderson, D., Moran, M.F., Ellis, C., and Pawson, T. (1991). SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252, 668-674.
30. Margolis, B., Hu, P., Katzav, S., Oliver, J.M., Ullrich, A., Weiss, A., and Schlessinger, J. (1992). Tyrosine phosphorylation of vav: a proto-oncogene combining SH2 and SH3 domains with motifs found in transcriptional factors. Nature 356, 71-74.
31. BCR/ABL. EMBO J. 14, 257-265.
32. Motto, D.G., Ross, E.E., Wu, J., Hendricks-Taylor, L.R., and Koretzky, G.A. (1996). Implication of the GRB2-associated phosphoprotein SLP-76 in TCR-mediated IL-2 production. J. Exp, Med., 183, 1937-1943.
33. vav associates with the nuclear protein Ku-70. Mol. Cell. Biol. 16, 37-44.
34. Sieh, M., Batzer, A., Schlessinger, J., and Weiss, A. (1994). GRB2 and phospholipase C-γ1 associate with a 36-to 38-kilodalton phosphotyrosine protein after T-cell receptor stimulation. Mol. Cell. Biol. 14, 4435-4442.
35. Smith, D., and Johnson, K. (1988). Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione-S-transferase. Gene 67, 31-40.
36. Songyang, Z., Shoelson, S.E., McGlade, J., Olivier, P., Pawson, T., Bustelo, X.R., Barbacid, M., Sabe, H., Hanafusa, H., Yi, T., Ren, R., Baltimore, D., Ratnofsky, S., Feldman, R.A., and Cantley, L.C. (1994). Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/ fes, GRB-2, HCP, SHC, Syk, and Vav. Mol. Cell. Biol. 14, 2777-2785.
37. Straus, D., and Weiss, A. (1992). Genetic evidence for the involvement of the Lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70, 585-593.
38. Tarakhovsky, A., Turner, M., Schaal, S., Joseph Mee, P., Duddy, L. P., Rajewsky, K., and Tybulewicz, V.L.J. (1995). Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 374, 467-470.
39. Wange, R.L., Kong, A.-N.T., and Samelson, L.E. (1992). A tyrosine-phosphorylated 70-kDa protein bind a photo affinity analogue of ATP and associates with both the ζ and CD3 components of the activated T cell antigen receptor. J. Biol. Chem. 267, 11685-11688.
40. Weiss, A., and Stobo, J.D. (1984). Requirement for the coexpression of T3 and the T cell antigen receptor on a malignant human T cell line. J. Exp. Med. 160, 1284-1299.
41. Weiss, A. and Littman, D.R. (1994). Signal transduction by lymphocyte antigen receptors. Cell 76, 263-274.
42. vav activity. Mol. Cell. Biol. 15, 4337-4346.
43. Ye, Z.-S., and Baltimore, D. (1994). Binding of Vav to Grb2 through dimerization of Src homology 3 domains. Proc. Natl. Acad. Sci. USA 91, 12629-12633.
44. Zhang, R., Alt, F.W., Davidson, L., Orkin, S.H., and Swat, W. (1995). Defective signaling through the T and B cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 374, 470-473.
45. Zmuidzinas, A., Fischer, K., Lira, S.A., Forrester, L, Bryant, S., Bernstein, A., and Barbacid, M. (1995). The vav proto-oncogene is required early in embryogenesis but not for hematopoietic development in vitro. EMBO J. 14, 1-11.